Solasia Pharma K.K. 9SO.F Stock
Solasia Pharma K.K. Price Chart
Solasia Pharma K.K. 9SO.F Financial and Trading Overview
Solasia Pharma K.K. stock price | 0.15 EUR |
Previous Close | 0.27 EUR |
Open | 0.28 EUR |
Bid | 0 EUR x N/A |
Ask | 0 EUR x N/A |
Day's Range | 0.27 - 0.27 EUR |
52 Week Range | 0.27 - 0.69 EUR |
Volume | 15 EUR |
Avg. Volume | 40 EUR |
Market Cap | 50.72M EUR |
Beta (5Y Monthly) | 1.405363 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.04 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
9SO.F Valuation Measures
Enterprise Value | -877961664 EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.042303372 |
Price/Book (mrq) | 0.018848315 |
Enterprise Value/Revenue | -0.732 |
Enterprise Value/EBITDA | 0.556 |
Trading Information
Solasia Pharma K.K. Stock Price History
Beta (5Y Monthly) | 1.405363 |
52-Week Change | -52.26% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.69 EUR |
52 Week Low | 0.27 EUR |
50-Day Moving Average | 0.29 EUR |
200-Day Moving Average | 0.34 EUR |
9SO.F Share Statistics
Avg. Volume (3 month) | 40 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 167.97M |
Float | 135.75M |
Short Ratio | N/A |
% Held by Insiders | 16.52% |
% Held by Institutions | 5.80% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -181.31% |
Operating Margin (ttm) | -176.47% |
Gross Margin | 59.04% |
EBITDA Margin | -131.77% |
Management Effectiveness
Return on Assets (ttm) | -43.44% |
Return on Equity (ttm) | -86.030% |
Income Statement
Revenue (ttm) | 1.2B EUR |
Revenue Per Share (ttm) | 7.47 EUR |
Quarterly Revenue Growth (yoy) | 94.69% |
Gross Profit (ttm) | 662M EUR |
EBITDA | -1580000000 EUR |
Net Income Avi to Common (ttm) | -2174000128 EUR |
Diluted EPS (ttm) | -0.09 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.02B EUR |
Total Cash Per Share (mrq) | 6.05 EUR |
Total Debt (mrq) | 90M EUR |
Total Debt/Equity (mrq) | 3.71 EUR |
Current Ratio (mrq) | 2.974 |
Book Value Per Share (mrq) | 14.431 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1282000000 EUR |
Levered Free Cash Flow (ttm) | -1303000064 EUR |
Profile of Solasia Pharma K.K.
Country | Germany |
State | N/A |
City | Tokyo |
Address | Sumitomo Fudosan Shiba-Koen Tower |
ZIP | 105-0011 |
Phone | 81 3 5843 8045 |
Website | https://www.solasia.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 27 |
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 a chemotherapy induced peripheral neuropathy which is in pre-clinical stage. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan.
Q&A For Solasia Pharma K.K. Stock
What is a current 9SO.F stock price?
Solasia Pharma K.K. 9SO.F stock price today per share is 0.15 EUR.
How to purchase Solasia Pharma K.K. stock?
You can buy 9SO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Solasia Pharma K.K.?
The stock symbol or ticker of Solasia Pharma K.K. is 9SO.F.
Which industry does the Solasia Pharma K.K. company belong to?
The Solasia Pharma K.K. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Solasia Pharma K.K. have in circulation?
The max supply of Solasia Pharma K.K. shares is 203.29M.
What is Solasia Pharma K.K. Price to Earnings Ratio (PE Ratio)?
Solasia Pharma K.K. PE Ratio is now.
What was Solasia Pharma K.K. earnings per share over the trailing 12 months (TTM)?
Solasia Pharma K.K. EPS is -0.04 EUR over the trailing 12 months.
Which sector does the Solasia Pharma K.K. company belong to?
The Solasia Pharma K.K. sector is Healthcare.